Straumann increases dividend again after good growth in 2024
Dental manufacturer Straumann continued to grow in 2024. However, the Basel-based company only partially achieved its own targets. For 2025, which is already underway, Straumann is being somewhat cautious as usual.Last year, Straumann generated sales of 2.5 billion Swiss francs, an increase of 3.7 percent. In organic terms – i.e. excluding exchange rate effects and acquisitions – Straumann grew by 13.7 percent. Compared to the previous year, when the increase was 9.8 percent, growth has therefore accelerated again somewhat.
In the Asia and EMEA region in particular, sales also rose sharply over the year as a whole. By contrast, sales growth in North America was comparatively modest at +3.6 percent.
At profit level, Straumann bases its own forecast on core operating profit (core EBIT), which is adjusted for items such as amortization from purchase price allocation, impairments, restructuring costs, etc. This rose to EUR 650 million and the core EBIT was EUR 650 million. This rose to 650 million and the corresponding margin was 26 percent. Straumann had set itself a target of 27 to 28 percent.
The bottom line was a profit of 439 million after 247 million in the previous year.
Straumann only partially met analysts’ expectations with these figures. While sales and organic growth were slightly above the AWP consensus, profits came in lower in some cases.
Higher dividend proposed
Shareholders are to receive a higher dividend of CHF 0.95 per share. This compares to CHF 0.85 in the previous year.
Looking ahead, the company is aiming for organic sales growth in the high single-digit percentage range and a core EBIT margin of 30 to 60 basis points compared to 2024.
